Cargando…

Cardiotoxicity associated with immune checkpoint inhibitors: Current status and future challenges

Immune checkpoint inhibitors (ICIs) are the most notable breakthrough in tumor treatment. ICIs has been widely used in tumor patients, but its wide range of immune-related adverse events (irAEs) should not be ignored. irAEs can be involved in any organ system, including immune-related cardiotoxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gan, Lu, Liu, Demin, Ma, Yanan, Chen, Xuening, Dai, Aihui, Zhao, Sihan, Jin, Xiaoxue, Gu, Guoqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468595/ https://www.ncbi.nlm.nih.gov/pubmed/36110551 http://dx.doi.org/10.3389/fphar.2022.962596

Ejemplares similares

Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
por: Zhou, Yu-Wen, et al.
Publicado: (2019)

Immune checkpoint inhibitors in osteosarcoma: A hopeful and challenging future
por: Zhang, Zeng, et al.
Publicado: (2022)

Cardiotoxicity Induced by Immune Checkpoint Inhibitors: A Pharmacovigilance Study From 2014 to 2019 Based on FAERS
por: Chen, Chenxin, et al.
Publicado: (2021)

Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and future perspectives
por: Liu, Zherui, et al.
Publicado: (2023)

Cardiotoxicity of immune checkpoint inhibitors
por: Varricchi, Gilda, et al.
Publicado: (2017)

Cardiotoxicity of Immune Checkpoint Inhibitors
por: Patel, Rushin P., et al.
Publicado: (2021)

Potential Therapeutic Options for COVID-19: Current Status, Challenges, and Future Perspectives
por: Sarkar, Chandan, et al.
Publicado: (2020)

First-Line Immune-Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Landscape and Future Progress
por: Huang, Zhangfeng, et al.
Publicado: (2020)

Pharmacogenomics in drug-induced cardiotoxicity: Current status and the future
por: Li, Mo-Yun, et al.
Publicado: (2022)

Cardiotoxicity from immune checkpoint inhibitors
por: Michel, Lars, et al.
Publicado: (2019)

The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
por: Nardi Agmon, Inbar, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors—Associated Cardiotoxicity
por: Li, Chenghui, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors Related to Cardiotoxicity
por: Chen, Ru, et al.
Publicado: (2022)

Cardiotoxicity Associated with Immune Checkpoint Inhibitors
por: Minegishi, Shintaro, et al.
Publicado: (2023)

Cardiotoxicity of Cancer Therapeutics: Current Issues in Screening, Prevention, and Therapy
por: Sheppard, Richard J., et al.
Publicado: (2013)

An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
por: Ye, Qingmei, et al.
Publicado: (2023)

Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
por: Shim, Jaehee V., et al.
Publicado: (2023)

Managing cardiotoxicity associated with immune checkpoint inhibitors
por: Upadhrasta, Sireesha, et al.
Publicado: (2019)

Cardiotoxicity risk factors with immune checkpoint inhibitors
por: Brumberger, Zachary L., et al.
Publicado: (2022)

Advances in immune checkpoint inhibitors induced-cardiotoxicity
por: Li, Xiang, et al.
Publicado: (2023)

Editorial: Food/Diet Supplements From Natural Sources: Current Status and Future Challenges From a Pharmacological Perspective
por: Tomczyk, Michał, et al.
Publicado: (2021)

Current status and future promise of next-generation poly (ADP-Ribose) polymerase 1-selective inhibitor AZD5305
por: Zheng, Jingcao, et al.
Publicado: (2023)

Nutraceuticals in the Modulation of the Intestinal Microbiota: Current Status and Future Directions
por: Spisni, Enzo, et al.
Publicado: (2022)

Inhibitors Targeting YAP in Gastric Cancer: Current Status and Future Perspectives
por: Yong, Jiaxin, et al.
Publicado: (2021)

Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma
por: Lin, Anqi, et al.
Publicado: (2021)

Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017)

Drug Development for the Irritable Bowel Syndrome: Current Challenges and Future Perspectives
por: De Ponti, Fabrizio
Publicado: (2013)

Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions
por: Wang, Yifan, et al.
Publicado: (2018)

Ferroptosis and Tumor Drug Resistance: Current Status and Major Challenges
por: Nie, Zhenyu, et al.
Publicado: (2022)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
por: Zulfiqar, Bilal, et al.
Publicado: (2022)

Platelets and platelet extracellular vesicles in drug delivery therapy: A review of the current status and future prospects
por: Dai, Zhanqiu, et al.
Publicado: (2022)

A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
por: Jin, Ying, et al.
Publicado: (2020)

Renal function protection and the mechanism of ginsenosides: Current progress and future perspectives
por: Fan, Meiling, et al.
Publicado: (2023)

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
por: Kumar, Vivek, et al.
Publicado: (2017)

Update on Novel Non-Operative Treatment for Osteoarthritis: Current Status and Future Trends
por: Chen, Tao, et al.
Publicado: (2021)

Editorial: Recent Advances in Cardiotoxicity Testing
por: Mohamed, Tamer M. A., et al.
Publicado: (2021)

Analysis of the efficacy of SGLT2 inhibitors using semi-mechanistic model
por: Demin, Oleg, et al.
Publicado: (2014)

Toxicity of Immune-Checkpoint Inhibitors in Hematological Malignancies
por: Hradska, Katarina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nu9omjr06073765m0l5ku166eb